BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8555463)

  • 1. Leukemia and lymphoma in ataxia telangiectasia.
    Taylor AM; Metcalfe JA; Thick J; Mak YF
    Blood; 1996 Jan; 87(2):423-38. PubMed ID: 8555463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome changes connect immunodeficiency and cancer in ataxia-telangiectasia.
    Hecht F; Hecht BK
    Am J Pediatr Hematol Oncol; 1987; 9(2):185-8. PubMed ID: 3496017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
    Ehrlich LA; Yang-Iott K; Bassing CH
    Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice.
    Liyanage M; Weaver Z; Barlow C; Coleman A; Pankratz DG; Anderson S; Wynshaw-Boris A; Ried T
    Blood; 2000 Sep; 96(5):1940-6. PubMed ID: 10961898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of secondary V(D)J rearrangements in mature, peripheral T cells of ataxia-telangiectasia heterozygotes.
    Lantelme E; Turinetto V; Mantovani S; Marchi A; Regazzoni S; Porcedda P; De Marchi M; Giachino C
    Lab Invest; 2003 Oct; 83(10):1467-75. PubMed ID: 14563948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia.
    Brito-Babapulle V; Catovsky D
    Cancer Genet Cytogenet; 1991 Aug; 55(1):1-9. PubMed ID: 1913594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic rearrangement of chromosome 14 in human lymphocytes.
    McCaw BK; Hecht F; Harnden DG; Teplitz RL
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2071-5. PubMed ID: 1056013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
    Marculescu R; Le T; Simon P; Jaeger U; Nadel B
    J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome abnormalities in leukemia and lymphoma.
    Rowley JD
    Ann Clin Lab Sci; 1983; 13(2):87-94. PubMed ID: 6602585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of chromosome abnormalities with histologic and immunologic characteristics in non-Hodgkin's lymphoma and adult T cell leukemia-lymphoma. Fifth International Workshop on Chromosomes in Leukemia-Lymphoma.
    Blood; 1987 Nov; 70(5):1554-64. PubMed ID: 2889485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.
    Petiniot LK; Weaver Z; Barlow C; Shen R; Eckhaus M; Steinberg SM; Ried T; Wynshaw-Boris A; Hodes RJ
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6664-9. PubMed ID: 10841564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VP16 hypersensitivity and increased faulty recombination in ataxia telangiectasia lymphocytes characterized by the tandem translocation t(14;14)(q11;q32).
    Petrinelli P; Elli R; Marcucci L; Barbieri C; Ambra R; Antonelli A
    Carcinogenesis; 1996 Feb; 17(2):203-7. PubMed ID: 8625439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subtle t(3;8) results in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma/leukemia and ataxia-telangiectasia.
    Sandlund JT; Kastan MB; Kennedy W; Behm F; Entrekin E; Pui CH; Kalwinsky DT; Raimondi SC
    Cancer Genet Cytogenet; 2006 Jul; 168(1):69-72. PubMed ID: 16772123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoid malignancy as a presenting sign of ataxia-telangiectasia.
    Loeb DM; Lederman HM; Winkelstein JA
    J Pediatr Hematol Oncol; 2000; 22(5):464-7. PubMed ID: 11037863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer susceptibility in ataxia-telangiectasia.
    Peterson RD; Funkhouser JD; Tuck-Muller CM; Gatti RA
    Leukemia; 1992; 6 Suppl 1():8-13. PubMed ID: 1548942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletions and rearrangement of CDKN2 in lymphoid malignancy.
    Stranks G; Height SE; Mitchell P; Jadayel D; Yuille MA; De Lord C; Clutterbuck RD; Treleaven JG; Powles RL; Nacheva E
    Blood; 1995 Feb; 85(4):893-901. PubMed ID: 7849311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juxtaposition of the T-cell receptor alpha-chain locus (14q11) and a region (14q32) of potential importance in leukemogenesis by a 14;14 translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia-telangiectasia.
    Davey MP; Bertness V; Nakahara K; Johnson JP; McBride OW; Waldmann TA; Kirsch IR
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9287-91. PubMed ID: 3194425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.
    Thick J; Metcalfe JA; Mak YF; Beatty D; Minegishi M; Dyer MJ; Lucas G; Taylor AM
    Oncogene; 1996 Jan; 12(2):379-86. PubMed ID: 8570215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
    Raghavan SC; Kirsch IR; Lieber MR
    J Biol Chem; 2001 Aug; 276(31):29126-33. PubMed ID: 11390401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia.
    Narducci MG; Virgilio L; Isobe M; Stoppacciaro A; Elli R; Fiorilli M; Carbonari M; Antonelli A; Chessa L; Croce CM; Russo G
    Blood; 1995 Sep; 86(6):2358-64. PubMed ID: 7662982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.